Moreover, we highlight the cGAS-STING signaling pathway as a potential mediator of the immune-activated tumor microenvironment in ARID1B-deficient cells, further enhancing our understanding of the complex interplay between genomic alterations and the immune system in cancer. The gene discussed is STING1; the disease is cancer.